EVAg

Institut Pasteur Paris - Access to BSL 3 containment facility. The access will comprise a detailed theoretical and subject to availability practical application of the biosafety and biosecurity management at Institut Pasteur. Among others, establishment and validation of suitable decontamination methods for waist, rooms and material, as well as documentation and information management will be addressed.

RNA extracted from cell cultuer supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from infectious cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

RNA extracted from cell culture supernatant

plasmid DNA of Influenza A NA A/PR/8/34 in a modified pHW2000 vector for reverse genetics (RG).

plasmid DNA of Influenza A PB1 A/PR/8/34 in a modified pHW2000 vector for reverse genetics (RG).

plasmid DNA of Influenza A PA A/PR/8/34 in a modified pHW2000

plasmid DNA of Influenza A NS A/PR/8/34 in a modified pHW2000 vector for reverse genetics (RG).

plasmid DNA of Influenza A NS A/PR/8/34 in a modified pHW2000 vector for reverse genetics (RG).

plasmid DNA of Influenza A NP A/PR/8/34 in a modified pHW2000 vector for reverse genetics (RG).

plasmid DNA of Influenza A MA A/PR/8/34 in a modified pHW2000 vector for reverse genetics (RG).

plasmid DNA of Influenza A HA A/PR/8/34 in a modified pHW2000 vector for reverse genetics (RG).

plasmid DNA of Influenza A/Black Headed Gull/Sweden/5/99 in a modified pHW2000 vector for reverse genetics (RG).